LFCR 8-K 2026-11-04

LIFECORE BIOMEDICAL, INC. \DE\ (LFCR) 8-K dated 2026-11-04 — accession 0001005286-26-000045.

LIFECORE BIOMEDICAL, INC. \DE\ (LFCR) is a drug manufacturers - specialty & generic company listed on NASDAQ.

LFCR: Lifecore Biomedical Reports Financial Results for the Third Quarter End…

This 8-K covers: Results of operations (Item 2.02), Exhibits (Item 9.01). SEC EDGAR holds the official filing and its exhibits.

Latest reported LFCR revenue for 2026-06-30 was $34.2M. Net income was -$6.2M. Revenue was up 47.3% from 2026-03-31 to 2026-06-30. LFCR currently screens at market cap $207.1M.

Not investment advice. The LFCR SEC hub lists recent forms. The stock page is the research view.